Interleukin 6 during active visceral leishmaniasis and after treatment
- 31 October 1995
- journal article
- research article
- Published by Elsevier in Clinical Immunology and Immunopathology
- Vol. 77 (1) , 111-114
- https://doi.org/10.1016/0090-1229(95)90144-2
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Mononuclear Cell Subpopulations and Cytokine Levels in Human Visceral Leishmaniasis before and after ChemotherapyThe Journal of Infectious Diseases, 1993
- The treatment of kala-azar in the Sudan with sodium stibogluconate: a randomized trial of three dosage regimensTransactions of the Royal Society of Tropical Medicine and Hygiene, 1993
- Immunology of LeishmaniasisAdvances in Parasitology, 1993
- Kala-azar: a comparative study of parasitological methods and the direct agglutination test in diagnosisTransactions of the Royal Society of Tropical Medicine and Hygiene, 1992
- Diminished In Vitro Production of Interleukin-1 and Tumor Necrosis Factor-α during Acute Visceral Leishmaniasis and Recovery after TherapyThe Journal of Infectious Diseases, 1992
- Contribution of non-Leishmania-specific immunity to resistance to Leishmania infection in humansClinical and Experimental Immunology, 1992
- Kala-azar in displaced people from southern Sudan: epidemiological, clinical and therapeutic findingsTransactions of the Royal Society of Tropical Medicine and Hygiene, 1991
- Sensitive ELISA for interleukin-6Journal of Immunological Methods, 1991
- Serum Tumor Necrosis Factor Levels and Disease Dissemination in Leprosy and LeishmaniasisThe Journal of Infectious Diseases, 1990
- RAISED SERUM LEVELS OF TUMOUR NECROSIS FACTOR IN PARASITIC INFECTIONSThe Lancet, 1986